Sir

I read with interest the article by Bhansali *et al*[@ref1] where beneficial effects of transplanting mesenchymal stem cells (MSCs) by tail vein injection in streptozotocin (STZ) treated rats were reported. Similar beneficial effects have been earlier reported by the same group after autologous bone marrow transplantation in patients with type 2 diabetes mellitus (T2DM)[@ref2].

The authors are requested to observe carefully [Figure 1](#F1){ref-type="fig"} of their article copied below ([Fig. 1](#F1){ref-type="fig"}). It clearly shows presence of a sub-population of very small embryonic-like stem cells (VSELs) in MSCs culture (circled) implying that a mix of MSCs and VSELs existed in their cultures. It was not clear from the information provided[@ref1] as to what passage cells were shown in the Figure and whether these cells were transplanted. The VSELs are observed very clearly in primary cultures and tend to get reduced in subsequent passages but these cells exist and also survive within the MSCs by a process termed 'emperopolesis'[@ref3]. We have earlier discussed about the presence of VSELs as a sub-population among MSCs[@ref4] and how OCT-4 (octamer-binding transcription factor-4) staining can differentiate these from each other. We have shown presence of VSELs in Haematoxylin and Eosin (H&E) stained smears prepared by enzymatically digesting mouse pancreas ([Fig. 2](#F2){ref-type="fig"}), characterized them and demonstrated how these are involved in regeneration of mice pancreas after more than 70 per cent of pancreas is surgically removed[@ref5]. Nuclear OCT-4 positive VSELs differentiated into cells (pancreas specific progenitors) with cytoplasmic OCT-4 which co-expressed pancreatic and duodenal homeobox-1 transcription factor (PDX-1)[@ref5]. Our results are in agreement with earlier reports where Ratajczak\'s group has reported a possible role for VSELs to improve pancreatic function after bone marrow transplantation (BMT)[@ref6] and also demonstrated an increased mobilization of VSELs in patients with pancreatic cancer[@ref7]. Whenever the pancreas function gets compromised, *e.g.* by pancreatectomy or by STZ treatment, VSELs get mobilized from the bone marrow and rush to the damaged pancreas in order to regenerate it. We have observed 6-folds increase in numbers of VSELs in pancreas of STZ treated mouse compared to normal control mouse pancreas (unpublished observations). Similar mobilization and a role of VSELs during hepatic regeneration was recently reported by Chen *et al*[@ref8]. Two other groups[@ref9][@ref10] have also reported presence of nuclear OCT-4 positive, very small sized cells in human pancreas (although they have not named them as VSELs).

![This is Figure 1 of the article by Bhansali *et al*[@ref1] showing VSELs (encircled) which have been missed out possibly because of the very small size. These cells have been ignored till now but are pluripotent stem cells that survive in various adult tissues throughout life. *Source*: [@ref1] (Reproduced with permission).](IJMR-143-111-g001){#F1}

![Haematoxylin & Eosin (H&E) stained smears of cells from normal mouse pancreas to appreciate the very small size of VSELs (arrow) at 10X, 20X and 40X. Cells marked in asterix are the pancreas specific progenitors. *Source*: [@ref5] (Reproduced with permission).](IJMR-143-111-g002){#F2}

The increase in numbers of islets in the transplanted group observed in the study[@ref1] is impressive but this may be due to differentiation of endogenous VSELs. It could be possible that STZ treatment mobilized VSELs into the rat pancreas which differentiated into islets. This was facilitated by the presence of healthy MSCs which were transplanted and acted as a source of growth factors. MSCs do not transdifferentiate into islets and this has been mentioned by the authors[@ref1] in their introduction. In a recent review we have discussed how VSELs have remained elusive till date and missed by various investigators because of their very small size and presence in very few numbers[@ref11].

We agree that transplanting MSCs will have a crucial role for regenerative medicine but it is important to first understand basic stem cells biology and recognize presence of VSELs in various adult tissues. Direct inter-tubular injection of Sertoli/mesenchymal cells in chemoablated (25mg/kg busulphan) mouse testis restored spermatogenesis[@ref12] from VSELs that survived due to their relatively quiescent nature. This was confirmed by the observation that transplanting green fluorescent protein (GFP) positive Sertoli/mesenchymal cells yielded non-green sperm[@ref12]. Further, a direct transplantation of MSCs in a diabetic mouse pancreas may be a better option than tail vein injection used by the authors[@ref1].
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